OCS Heart System Earns Hard-Won Backing of FDA Panel
After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support
Read more
After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support
Read moreAfter more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support
Read morePatients at high risk for heart attacks, strokes and blood clots who were treated with a novel blood thinner (apixaban)
Read more(HealthDay)—Accepting a liver from an older liver donor (OLD) is associated with long-term survival benefit, according to a study presented
Read more